Delivery Order SPE2DR25D2100-SPE2DR26FA0MT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, with a contract value of $1,096.68. This firm fixed price delivery order is set to be completed by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting the company's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, valued at $3,139.63. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to support federal medical procurement needs. The work is scheduled for completion by October 17, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,071.90 to AmerisourceBergen Drug Corp for the supply of Sucralfate 1 GM tablets (100 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00...
- This is a delivery order under Contract SPE2DX15D1053 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,562,782,604 units of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price ceiling of $3,274.80. The contract has an ultimate completion date of November 13, 2023. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov)...
- The Defense Logistics Agency awarded a $2,290.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sucralfate oral suspension. The contract calls for the delivery of 420 milliliters of sucralfate 1 gram per 10 milliliters oral suspension to a facility in Conshohocken, Pennsylvania. Performance is required between September 28 and 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,227.03, is for the supply of 4,565,891,255 units of Sucralfate 1 GM/10 ML Suspension in 420ML containers. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- This federal contract award, valued at $1,067.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gm/10 ml suspension in 420 ml containers. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- The Defense Logistics Agency awarded a $3,853.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561452200 sucralfate 1 gm/10 ml susp ud 10ml. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for delivery of the specified pharmaceutical product between July 10-11, 2023. DLA utilizes indefinite delivery vehicle contracts to supply medical materiel to various DoD components, and this order was placed under one such...
- This federal contract award, valued at $6,470.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, designated as a Delivery Order under an Indefinite Delivery Contract (IDC), covers the supply of 4,566,760,172 units of Sucralfate 1 GM Tablet 90S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. This award is part of Amerisourcebergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,584.03 order is for 90 tablets of 1 gram sucralfate, a medication used to treat peptic ulcers. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract to supply pharmaceuticals and medical supplies to support DLA Troop Support Medical...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0MTDelivery Order
The Defense Logistics Agency awarded a $1,772.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sucralfate 1 GM/10 ML Suspension in a 420 ML quantity. This award, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains and has demonstrated capability to fulfill federal requirements through open competition. This award for Sucralfate, a gastric protective medication, exemplifies the routine pharmaceutical supply operations conducted under the company's prime vendor agreement, which enables flexible support to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/8/25 |